logo
Select company
Select metric
$ -169.79MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
5
Sector
11
Industry
16
History
8
$ 1.01Close
$ 0.53 - $ 4.4 52-Week Range
Ticker Information

Ticker

STRO

Company Name

SUTRO BIOPHARMA INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SUTRO BIOPHARMA INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STRO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 12.96M$ -182.75M$ -169.79M
3/31/2025$ 12.67M$ -218.53M$ -205.86M
12/31/2024$ 12.36M$ -199.32M$ -186.96M
9/30/2024$ 12.05M$ -79.46M$ -67.41M
6/30/2024$ 11.83M$ -97.55M$ -85.72M
3/31/2024$ 11.17M$ -86.75M$ -75.58M
12/31/2023$ 10.44M$ -77.42M$ -66.98M
9/30/2023$ 9.69M$ -162.12M$ -152.43M
6/30/2023$ 8.89M$ -134.11M$ -125.22M
3/31/2023$ 8.55M$ -121.57M$ -113.03M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SUTRO BIOPHARMA INC's latest trailing twelve months (TTM) EBITDA stands at $ 24.11M.
  • Over the past 5 years, SUTRO BIOPHARMA INC's average EBITDA has been $ -99.85M.
  • The median EBITDA for SUTRO BIOPHARMA INC during this period was $ -102.97M
  • SUTRO BIOPHARMA INC reached its highest EBITDA over the past 5 years at $ 24.11M.
  • The lowest EBITDA recorded by SUTRO BIOPHARMA INC in the same timeframe $ -205.86M

SUTRO BIOPHARMA INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
IPSC : CENTURY THERAPEUTICS INC $ -7.37MIGMS : IGM BIOSCIENCES INC $ -41.96MFBIO : FORTRESS BIOTECH INC $ 6.15MDOMH : DOMINARI HOLDINGS INC $ -18.5MMGX : METAGENOMI INC $ -79.73MASRT : ASSERTIO HOLDINGS INC $ -8.2MLUNG : PULMONX CORP $ -50.59MKPTI : KARYOPHARM THERAPEUTICS INC $ -78.44MICCC : IMMUCELL CORP $ 4.47MATRA : ATARA BIOTHERAPEUTICS INC $ 24.86M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for SUTRO BIOPHARMA INC is calculated as follows: EBIT [ $ 19.77M ] + DepAmor [ $ 4.34M ]
(=) EBITDA [ $ 24.11M ]

STRO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -205.86M

Minimum

Mar 31, 2025

$ 24.11M

Maximum

Sep 30, 2020

$ -99.85M

Average

$ -102.97M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.79M
median$ 8.83M
std$ 166.94M